Institution benchmarking
The positions shown in the tables below are based on the Share of an institution's research output overall and in each subject area globally.
Overall
Institution | 2018 | 2019 | 2020 | 2021 | 2022 | Present |
---|---|---|---|---|---|---|
Axcelead Drug Discovery Partners, Inc., Japan | - | - | - | - | - | - |
Biological sciences
Institution | 2018 | 2019 | 2020 | 2021 | 2022 | Present |
---|---|---|---|---|---|---|
Axcelead Drug Discovery Partners, Inc., Japan | - | - | - | - | - | - |
Chemistry
Institution | 2018 | 2019 | 2020 | 2021 | 2022 | Present |
---|---|---|---|---|---|---|
Axcelead Drug Discovery Partners, Inc., Japan | - | - | - | - | - | - |
Earth & environmental sciences
Institution | 2018 | 2019 | 2020 | 2021 | 2022 | Present |
---|---|---|---|---|---|---|
Axcelead Drug Discovery Partners, Inc., Japan | - | - | - | - | - | - |
Health sciences
Institution | 2022 | Present |
---|---|---|
Axcelead Drug Discovery Partners, Inc., Japan | - | - |
Physical sciences
Institution | 2018 | 2019 | 2020 | 2021 | 2022 | Present |
---|---|---|---|---|---|---|
Axcelead Drug Discovery Partners, Inc., Japan | - | - | - | - | - | - |
![Creative Commons License](https://i.creativecommons.org/l/by-nc-sa/4.0/80x15.png)
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Comprehensive deep-dives and custom high-quality reports
Nature Strategy Reports gives you simple insights into what matters most
The reports created for you by our subject matter experts combine compelling insights with Nature’s trust and authority. Get an in-depth analysis of your and your peers’ research performance, including a breakdown of relative strengths and weaknesses. All of which is crafted using data and tools from across Nature Research Intelligence, covering all major disciplines and all regions of the world.